Watch Dr. Eva Feldman's acceptance speech for the Michigan Medicine Alumni Society's 2019 Distinguished Alumnus Achievement Award. The presentation took place at Homecoming 2019.
Scientist, Doctor, Mom: Dr. Eva Feldman Continues to be a Champion and Trailblazer for Women in Science.
In honor of Eva Feldman, M.D., Ph.D., being named the 2019 Distinguished Achievement Award recipient from the Michigan Medicine Alumni Society, Congresswoman Debbie DIngell recognized her in the U.S. Congressional Record.
A member of the board of directors for the M.V. Hospital for Diabetes in India, Dr. Feldman gave a presentation entitled "Diagnosis of Diabetic Neuropathy in the Clinical Setting: What Should a Clinician Know?”
The Rose C and Nathan L Milstein Family Foundation’s $500,000 donation will support a junior faculty member researching diabetes. Pictured is Dr. Eva Feldman, Alene Lipshaw, who is the grand daughter of the Milsteins, and Dr. Stephanie Eid, whose research will benefit from the fund.
Dr. Stephen Goutman has developed a new clinical rating scale for ALS, which can be used in drug trials to measure disease progression.
Drs. Kim and Elzinga report that proteins in the brain known to promote Alzheimer’s disease are significantly increased in response to eating a high fat diet and becoming obese.
Dr. Ahmed Ali discovered that replacing the injured portion of the facial nerve in a rodent model with an easily accessible sensory nerve restored facial nerve function.
Dr. Sarah Elzinga and Dr. Benjamin Murdock report that the blocking of specific immune system proteins could be a new therapeutic approach for neuropathy.
Dr. Stephanie Eid reviews the current state of our understanding of how type 2 diabetes damages the nerve, retina and kidney in patients, and how this damage may be secondary to high blood levels of lipids.
Dr. Eva Feldman joined Detroit Public Television's Colleen O'Donnell on Facebook Live in advance of the airing of "Collateral Damage," a documentary about ALS in which she was featured.
Former members of Michigan Wolverine basketball joined the ALS Center of Excellence for Hoops Fight ALS—a program of events to raise money for the University of Michigan's ALS clinic and its research.
A blood test for Alzheimer’s disease – what benefit does early detection hold without a cure?
Awarded at the 2019 PNS Annual Meeting in Genoa Italy, the Gebhart Prize recognizes Dr. Feldman’s contributions to the PNS mission: supporting research, training scientists, setting standards of care, creating new treatments, and facilitating clinical trials. Ten PNR&D scientists and staff attended and presented at the conference.
Jon Gerych, Jim Hiller, Lisa Rosenberg and Dr. Brian Roth have joined the U-M ALS Center of Excellence National Advisory Board. Their addition brings the total number of board members to 16.
Dr. Brian Callaghan discussed his recent drug cost research on Michigan Radio's Stateside program. His research investigated the sharp rise in drug costs to patients suffering from neurologic diseases.
Recently published in Neurology , Dr. Brian Callaghan (right) contends that neurologists have a duty to their patients to consider financial burdens when prescribing medications.
Research from Drs. Sarah Elzinga, Stephanie Eid and Kai Guo shows that the activity of the genes with which you are born can be changed during your lifetime by the environment and by chronic diseases, such as type 2 diabetes.
PNR&D is hosting its second visiting scholar, Mohamed El Massry, who is spending five weeks this spring in the aboratory to learn how to assess nerve structure and function in diabetes.
Dr. Eva Feldman was the keynote speaker at the Susan Mast<br>ALS Foundation Luncheon on May 20 in Grand Rapids,<br>Michigan.
